Dingxie Liu

3.6k total citations · 1 hit paper
46 papers, 2.7k citations indexed

About

Dingxie Liu is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Oncology. According to data from OpenAlex, Dingxie Liu has authored 46 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 21 papers in Endocrinology, Diabetes and Metabolism and 19 papers in Oncology. Recurrent topics in Dingxie Liu's work include Thyroid Cancer Diagnosis and Treatment (21 papers), Cancer-related Molecular Pathways (9 papers) and Epigenetics and DNA Methylation (7 papers). Dingxie Liu is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (21 papers), Cancer-related Molecular Pathways (9 papers) and Epigenetics and DNA Methylation (7 papers). Dingxie Liu collaborates with scholars based in United States, China and Italy. Dingxie Liu's co-authors include Mingzhao Xing, Peng Hou, Adel K. El‐Naggar, Avaniyapuram Kannan Murugan, Shan Yuan, Shuiying Hu, Sara I. Pai, Xiaoli Liu, Hui Sun and Justin A. Bishop and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and JNCI Journal of the National Cancer Institute.

In The Last Decade

Dingxie Liu

46 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Highly prevalent TERT promoter mutations in aggressive thyroid cancers

2013 460 citations Dingxie Liu, Avaniyapuram Kannan Murugan et al. Endocrine Related Cancer profile →

Peers

Dingxie Liu

EDM

ONCOL

GENET

Efisio Puxeddu Italy

Aneeta Patel United States

Marialuisa Sponziello Italy

Abdul K. Siraj Saudi Arabia

Bingyin Shi China

H. Rabes Germany

Marcus V. Cronauer Germany

Sébastien Jeay Switzerland

Tarja Ikonen Finland

Yoshitatsu Fukabori Japan

Efisio Puxeddu Italy

Dingxie Liu

2.0k ×1.4

EDM

1.3k ×0.9

905 ×1.0

ONCOL

355 ×0.7

GENET

257 ×0.7

Citations per year, relative to Dingxie Liu Dingxie Liu (= 1×) peers Efisio Puxeddu

Countries citing papers authored by Dingxie Liu

Since Specialization

Citations

This map shows the geographic impact of Dingxie Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dingxie Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dingxie Liu more than expected).

Fields of papers citing papers by Dingxie Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dingxie Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dingxie Liu. The network helps show where Dingxie Liu may publish in the future.

Co-authorship network of co-authors of Dingxie Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Dingxie Liu. A scholar is included among the top collaborators of Dingxie Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dingxie Liu. Dingxie Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Dingxie & Paul Hofman. (2022). Expression of NOTCH1, NOTCH4, HLA-DMA and HLA-DRA is synergistically associated with T cell exclusion, immune checkpoint blockade efficacy and recurrence risk in ER-negative breast cancer. Cellular Oncology. 45(3). 463–477. 15 indexed citations

Liu, Dingxie, Jaydutt V. Vadgama, & Yong Wu. (2021). Basal-like breast cancer with low TGFβ and high TNFα pathway activity is rich in activated memory CD4 T cells and has a good prognosis. International Journal of Biological Sciences. 17(3). 670–682. 20 indexed citations

Liu, Dingxie & Yong Wu. (2020). Association of an anaplastic lymphoma kinase pathway signature with cell de‐differentiation, neoadjuvant chemotherapy response, and recurrence risk in breast cancer. Cancer Communications. 40(9). 422–434. 7 indexed citations

Liu, Dingxie. (2020). AR pathway activity correlates with AR expression in a HER2-dependent manner and serves as a better prognostic factor in breast cancer. Cellular Oncology. 43(2). 321–333. 14 indexed citations

Liu, Dingxie. (2019). Concomitant dysregulation of the estrogen receptor and BRAF/MEK signaling pathways is common in colorectal cancer and predicts a worse prognosis. Cellular Oncology. 42(2). 197–209. 8 indexed citations

Liu, Dingxie, et al.. (2013). Histone deacetylation of NIS promoter underlies BRAF V600E-promoted NIS silencing in thyroid cancer. Endocrine Related Cancer. 21(2). 161–173. 78 indexed citations

Liu, Dingxie, et al.. (2013). Identification of RASAL1 as a Major Tumor Suppressor Gene in Thyroid Cancer. JNCI Journal of the National Cancer Institute. 105(21). 1617–1627. 70 indexed citations

Hou, Peng, Dingxie Liu, Jianli Dong, & Mingzhao Xing. (2012). The BRAFV600E causes widespread alterations in gene methylation in the genome of melanoma cells. Cell Cycle. 11(2). 286–295. 72 indexed citations

Xing, Jeffrey C., Ralph P. Tufano, Avaniyapuram Kannan Murugan, et al.. (2012). Single Nucleotide Polymorphism rs17849071 G/T in the PIK3CA Gene Is Inversely Associated with Follicular Thyroid Cancer and PIK3CA Amplification. PLoS ONE. 7(11). e49192–e49192. 16 indexed citations

10.

Liu, Ruixin, et al.. (2011). The Akt-Specific Inhibitor MK2206 Selectively Inhibits Thyroid Cancer Cells Harboring Mutations That Can Activate the PI3K/Akt Pathway. The Journal of Clinical Endocrinology & Metabolism. 96(4). E577–E585. 90 indexed citations

11.

Hou, Peng, Dingxie Liu, & Mingzhao Xing. (2011). Genome-wide alterations in gene methylation by the BRAF V600E mutation in papillary thyroid cancer cells. Endocrine Related Cancer. 18(6). 687–697. 69 indexed citations

12.

Liu, Zhi, Dingxie Liu, Ermal Bojdani, et al.. (2010). IQGAP1 Plays an Important Role in the Invasiveness of Thyroid Cancer. Clinical Cancer Research. 16(24). 6009–6018. 55 indexed citations

13.

Gilbert, Elizabeth R. & Dingxie Liu. (2010). Flavonoids Influence Epigenetic-Modifying Enzyme Activity: Structure-Function Relationships and the Therapeutic Potential for Cancer. Current Medicinal Chemistry. 17(17). 1756–1768. 78 indexed citations

14.

Liu, Dingxie, Peng Hou, Zhi Liu, Guojun Wu, & Mingzhao Xing. (2009). Genetic Alterations in the Phosphoinositide 3-Kinase/Akt Signaling Pathway Confer Sensitivity of Thyroid Cancer Cells to Therapeutic Targeting of Akt and Mammalian Target of Rapamycin. Cancer Research. 69(18). 7311–7319. 75 indexed citations

15.

Cui, Yan, Ying Ying, Andrew van Hasselt, et al.. (2008). OPCML Is a Broad Tumor Suppressor for Multiple Carcinomas and Lymphomas with Frequently Epigenetic Inactivation. PLoS ONE. 3(8). e2990–e2990. 87 indexed citations

16.

Wang, Yuxuan, Meiju Ji, Zhi‐Feng Miao, et al.. (2008). Association of the T1799A BRAF mutation with tumor extrathyroidal invasion, higher peripheral platelet counts, and over-expression of platelet-derived growth factor-B in papillary thyroid cancer. Endocrine Related Cancer. 15(1). 183–190. 39 indexed citations

17.

Hu, Shuiying, Marge Ewertz, Ralph P. Tufano, et al.. (2006). Detection of Serum Deoxyribonucleic Acid Methylation Markers: A Novel Diagnostic Tool for Thyroid Cancer. The Journal of Clinical Endocrinology & Metabolism. 91(1). 98–104. 46 indexed citations

18.

Hu, Shuiying, Dingxie Liu, Ralph P. Tufano, et al.. (2006). Association of aberrant methylation of tumor suppressor genes with tumor aggressiveness and BRAF mutation in papillary thyroid cancer. International Journal of Cancer. 119(10). 2322–2329. 157 indexed citations

19.

Luo, Kangxian, Haitang He, Zhihua Liu, et al.. (2002). Novel variants related to TT virus distributed widely in China*. Journal of Medical Virology. 67(1). 118–126. 37 indexed citations

20.

Liu, Dingxie. (2001). A new hypothesis of pathogenetic mechanism of viral hepatitis B and C. Medical Hypotheses. 56(3). 405–408. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact